Citation Formats
Rottlerin inhibits tumor progression through MAPK ERK pathway and cyclin D1 in human lung cancer cells
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

H. A. BİRCAN Et Al. , "Rottlerin inhibits tumor progression through MAPK ERK pathway and cyclin D1 in human lung cancer cells," EACR-sponsored 2nd Anticancer Agents Congress & 5th Multidisciplinary Cancer Research Congress , Bodrum, Turkey, 2014

BİRCAN, H. A. Et Al. 2014. Rottlerin inhibits tumor progression through MAPK ERK pathway and cyclin D1 in human lung cancer cells. EACR-sponsored 2nd Anticancer Agents Congress & 5th Multidisciplinary Cancer Research Congress , (Bodrum, Turkey).

BİRCAN, H. A., GÜRBÜZ, N., ERDOĞAN, M. A., & OZPOLAT, B., (2014). Rottlerin inhibits tumor progression through MAPK ERK pathway and cyclin D1 in human lung cancer cells . EACR-sponsored 2nd Anticancer Agents Congress & 5th Multidisciplinary Cancer Research Congress, Bodrum, Turkey

BİRCAN, Hacı Et Al. "Rottlerin inhibits tumor progression through MAPK ERK pathway and cyclin D1 in human lung cancer cells," EACR-sponsored 2nd Anticancer Agents Congress & 5th Multidisciplinary Cancer Research Congress, Bodrum, Turkey, 2014

BİRCAN, Hacı A. Et Al. "Rottlerin inhibits tumor progression through MAPK ERK pathway and cyclin D1 in human lung cancer cells." EACR-sponsored 2nd Anticancer Agents Congress & 5th Multidisciplinary Cancer Research Congress , Bodrum, Turkey, 2014

BİRCAN, H. A. Et Al. (2014) . "Rottlerin inhibits tumor progression through MAPK ERK pathway and cyclin D1 in human lung cancer cells." EACR-sponsored 2nd Anticancer Agents Congress & 5th Multidisciplinary Cancer Research Congress , Bodrum, Turkey.

@conferencepaper{conferencepaper, author={Hacı Ahmet BİRCAN Et Al. }, title={Rottlerin inhibits tumor progression through MAPK ERK pathway and cyclin D1 in human lung cancer cells}, congress name={EACR-sponsored 2nd Anticancer Agents Congress & 5th Multidisciplinary Cancer Research Congress}, city={Bodrum}, country={Turkey}, year={2014}}